发明名称 NOVEL AMINO IMIDAZOLE COMPOUNDS SELECTIVELY SUPPRESS OXIDATIVE STRESS INDUCED NEURODEGENERATION
摘要 An object of the present invention is to provide a pharmaceutical agent useful for treating and preventing neurological disease, having satisfactory solubility and oxidative stress-mediated cell death suppressive activity as well as capable of exhibiting excellent blood-brain barrier permeability. The present invention is directed to an acylaminoimidazole derivative represented by general formula (I) or a salt thereof, and a pharmaceutical and a therapeutic or preventive agent for neurological disease containing the same, as an active ingredient. (see formula I)
申请公布号 CA2806766(C) 申请公布日期 2017.01.10
申请号 CA20112806766 申请日期 2011.07.15
申请人 NEUGEN PHARMA INC.;WAKUNAGA PHARMACEUTICAL CO., LTD. 发明人 INOUE, SATOSHI;IKEDA, JOH-E;HIRAYAMA, NORIAKI;TANAKA, KAZUNORI;KANNO, TAKUYA
分类号 C07D233/88;A61K31/4168;A61K31/4439;A61P25/00;A61P25/02;A61P25/16;A61P25/28;A61P43/00;C07D401/04 主分类号 C07D233/88
代理机构 代理人
主权项
地址